BioWorld - Monday, December 23, 2024
See today's BioWorld
X

Upgrade your daily dose of biopharma and medtech news

Subscribe to BioWorld™ news services

See subscription options
To read the full story, subscribe or sign in.

Cardio’s working out as players flex in heart failure

July 8, 2021
By Randy Osborne
No Comments
Recent findings with the sodium glucose transporter-2 inhibitor Jardiance (empagliflozin) from Boehringer Ingelheim International GmbH and Eli Lilly and Co. drew more attention to the cardiovascular space.
BioWorld Clinical Cardiovascular